Assessing key assumptions of network meta‐analysis: a review of methods

BACKGROUND Homogeneity and consistency assumptions underlie network meta-analysis (NMA). Methods exist to assess the assumptions but they are rarely and poorly applied. We review and illustrate methods to assess homogeneity and consistency. METHODS Eligible articles focussed on indirect comparison or NMA methodology. Articles were sought by hand-searching and scanning references (March 2013). Assumption assessment methods described in the articles were reviewed, and applied to compare anti-malarial drugs. RESULTS 116 articles were included. Methods to assess homogeneity were: comparing characteristics across trials; comparing trial-specific treatment effects; using hypothesis tests or statistical measures; applying fixed-effect and random-effects pair-wise meta-analysis; and investigating treatment effect-modifiers. Methods to assess consistency were: comparing characteristics; investigating treatment effect-modifiers; comparing outcome measurements in the referent group; node-splitting; inconsistency modelling; hypothesis tests; back transformation; multidimensional scaling; a two-stage approach; and a graph-theoretical method. For the malaria example, heterogeneity existed for some comparisons that was unexplained by investigating treatment effect-modifiers. Inconsistency was detected using node-splitting and inconsistency modelling. It was unclear whether the covariates explained the inconsistency. CONCLUSIONS Presently, we advocate applying existing assessment methods collectively to gain the best understanding possible regarding whether assumptions are reasonable. In our example, consistency was questionable; therefore the NMA results may be unreliable.

[1]  Philippe Ravaud,et al.  Adjustment for reporting bias in network meta-analysis of antidepressant trials , 2012, BMC Medical Research Methodology.

[2]  Catrin Tudur Smith,et al.  Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta‐analysis: individual patient‐level covariates versus aggregate trial‐level covariates , 2012, Statistics in medicine.

[3]  Julian P T Higgins,et al.  A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. , 2009, Journal of clinical epidemiology.

[4]  Steven A. Julious,et al.  How Biased are Indirect Comparisons, Particularly When Comparisons are Made over Time in Controlled Trials? , 2008 .

[5]  Nicky J Welton,et al.  Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. , 2009, American journal of epidemiology.

[6]  Andrew R Willan,et al.  Indirect comparison: relative risk fallacies and odds solution. , 2009, Journal of clinical epidemiology.

[7]  Daniel C Malone,et al.  Using indirect comparisons in pharmacoeconomic studies--time for implementation. , 2007, Clinical therapeutics.

[8]  Gerta Rücker,et al.  Network meta‐analysis, electrical networks and graph theory , 2012, Research synthesis methods.

[9]  Laura Bojke,et al.  Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[11]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[12]  J. Jansen Network meta-analysis of survival data with fractional polynomials , 2011, BMC medical research methodology.

[13]  Thomas Lumley,et al.  Graphical exploration of network meta-analysis data: the use of multidimensional scaling , 2008, Clinical trials.

[14]  Neil Hawkins,et al.  No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  Nicky J Welton,et al.  Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open‐angle glaucoma and ocular hypertension , 2011, Statistics in medicine.

[16]  Joseph C Cappelleri,et al.  Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  I Harvey,et al.  Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. , 2008, Journal of clinical epidemiology.

[18]  Georgia Salanti,et al.  Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons. , 2012, Journal of clinical epidemiology.

[19]  A E Ades,et al.  Accounting for correlation in network meta‐analysis with multi‐arm trials , 2012, Research synthesis methods.

[20]  Kristian Thorlund,et al.  Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution? , 2013, BMC Medical Research Methodology.

[21]  A. Ades ISPOR states its position on network meta-analysis. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  Kristian Thorlund,et al.  Estimating the Power of Indirect Comparisons: A Simulation Study , 2011, PloS one.

[23]  Joseph C. Cappelleri,et al.  Use of Mixed Treatment Comparisons in Systematic Reviews , 2012 .

[24]  Philippe Ravaud,et al.  Impact of Reporting Bias in Network Meta-Analysis of Antidepressant Placebo-Controlled Trials , 2012, PloS one.

[25]  S Dias,et al.  Checking consistency in mixed treatment comparison meta‐analysis , 2010, Statistics in medicine.

[26]  Daniel E Jonas,et al.  Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation , 2013 .

[27]  Fujian Song,et al.  Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons , 2012, BMC Medical Research Methodology.

[28]  Tommi Tervonen,et al.  Multicriteria benefit-risk assessment using network meta-analysis. , 2012, Journal of clinical epidemiology.

[29]  Guobing Lu,et al.  Modeling between-trial variance structure in mixed treatment comparisons. , 2009, Biostatistics.

[30]  Nicky J Welton,et al.  Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories , 2010, Statistics in medicine.

[31]  M. Coory,et al.  Frequency of Treatment-EffectModification Affecting Indirect Comparisons , 2010, PharmacoEconomics.

[32]  S Wordsworth,et al.  Indirect comparisons of treatments based on systematic reviews of randomised controlled trials , 2009, International journal of clinical practice.

[33]  Nicky J Welton,et al.  How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  Nicky J Welton,et al.  Evaluating novel agent effects in multiple‐treatments meta‐regression , 2010, Statistics in medicine.

[35]  Bruno Falissard,et al.  Real medical benefit assessed by indirect comparison. , 2009, Therapie.

[36]  Nicky J Welton,et al.  Linear inference for mixed treatment comparison meta‐analysis: A two‐stage approach , 2011, Research synthesis methods.

[37]  Dimitris Mavridis,et al.  Network meta‐analysis models to account for variability in treatment definitions: application to dose effects , 2013, Statistics in medicine.

[38]  Huseyin Naci,et al.  Using Indirect Evidence to Determine the Comparative Effectiveness of Prescription Drugs: Do Benefits Outweigh Risks? , 2011 .

[39]  N. Welton,et al.  Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation , 2009, Statistics in medicine.

[40]  Jason Madan,et al.  Consistency between direct and indirect trial evidence: is direct evidence always more reliable? , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[41]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[42]  Tianjing Li,et al.  Network meta-analysis-highly attractive but more methodological research is needed , 2011, BMC medicine.

[43]  A Whitehead,et al.  Borrowing strength from external trials in a meta-analysis. , 1996, Statistics in medicine.

[44]  Morgen M. Miller,et al.  Rank reversal in indirect comparisons. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[45]  David C Hoaglin,et al.  Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[46]  A. Marson,et al.  Multiple treatment comparisons in epilepsy monotherapy trials , 2007, Trials.

[47]  Javier Ballesteros,et al.  Orphan Comparisons and Indirect Meta-analysis: A Case Study on Antidepressant Efficacy in Dysthymia Comparing Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, and Monoamine Oxidase Inhibitors by Using General Linear Models , 2005, Journal of clinical psychopharmacology.

[48]  B. Vandermeer,et al.  Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic Insomnia in Adults: A Case Study , 2007, Medical care.

[49]  AE Ades,et al.  Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies‡ , 2012, Research synthesis methods.

[50]  Deborah M Caldwell,et al.  Selecting the best scale for measuring treatment effect in a network meta‐analysis: a case study in childhood nocturnal enuresis , 2012, Research synthesis methods.

[51]  Deborah M Caldwell,et al.  NICE DSU Technical Support Document 7: Evidence Synthesis of Treatment Efficacy in Decision Making: A Reviewer’s Checklist , 2012 .

[52]  A E Ades,et al.  Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B , 2008, Statistics in medicine.

[53]  Alex J Sutton,et al.  Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study , 2011, BMJ : British Medical Journal.

[54]  H. Fu,et al.  Bayesian indirect and mixed treatment comparisons across longitudinal time points , 2013, Statistics in medicine.

[55]  Neil Hawkins,et al.  Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention. , 2012, Journal of clinical epidemiology.

[56]  Kristian Thorlund,et al.  Multiple treatment comparison meta-analyses: a step forward into complexity , 2011, Clinical epidemiology.

[57]  Tommi Tervonen,et al.  Algorithmic parameterization of mixed treatment comparisons , 2011, Statistics and Computing.

[58]  Heinz Schmidli,et al.  The network meta-analytic-predictive approach to non-inferiority trials , 2013, Statistical methods in medical research.

[59]  Gerald Gartlehner,et al.  Direct versus indirect comparisons: A summary of the evidence , 2008, International Journal of Technology Assessment in Health Care.

[60]  Paula Williamson,et al.  Indirect Comparisons: A Review of Reporting and Methodological Quality , 2010, PloS one.

[61]  G. Lu,et al.  Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .

[62]  A. Sutton,et al.  Mixed treatment comparisons using aggregate and individual participant level data , 2012, Statistics in medicine.

[63]  A Cipriani,et al.  What is a multiple treatments meta-analysis? , 2012, Epidemiology and Psychiatric Sciences.

[64]  A. Cipriani,et al.  Validity of indirect comparisons in meta-analysis , 2007, The Lancet.

[65]  Hans-Peter Piepho,et al.  The Use of Two‐Way Linear Mixed Models in Multitreatment Meta‐Analysis , 2012, Biometrics.

[66]  Georgia Salanti,et al.  Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool , 2012, Research synthesis methods.

[67]  S. Senn,et al.  Issues in performing a network meta-analysis , 2013, Statistical methods in medical research.

[68]  Sibylle Sturtz,et al.  Unsolved issues of mixed treatment comparison meta‐analysis: network size and inconsistency , 2012, Research synthesis methods.

[69]  D G Altman,et al.  Indirect comparisons of competing interventions. , 2005, Health technology assessment.

[70]  Keith Abrams,et al.  Use of Indirect and Mixed Treatment Comparisons for Technology Assessment , 2012, PharmacoEconomics.

[71]  Georgia Salanti,et al.  Research Synthesis Methods special issue on network meta‐analysis: introduction from the editors , 2012, Research synthesis methods.

[72]  Kristian Thorlund,et al.  Sample size and power considerations in network meta-analysis , 2012, Systematic Reviews.

[73]  Douglas G Altman,et al.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.

[74]  J. Borrill,et al.  Network meta-analysis: importance of appropriate trial selection. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[75]  Dan Jackson,et al.  Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression‡ , 2012, Research synthesis methods.

[76]  Byron Jones,et al.  Statistical approaches for conducting network meta‐analysis in drug development , 2011, Pharmaceutical statistics.

[77]  Nicky J Welton,et al.  Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta‐analysis , 2010 .

[78]  Jeroen P Jansen,et al.  Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[79]  Anna Chaimani,et al.  Using network meta‐analysis to evaluate the existence of small‐study effects in a network of interventions , 2012, Research synthesis methods.

[80]  V. Hasselblad,et al.  Meta-analysis of Multitreatment Studies , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[81]  Sofia Dias,et al.  Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta‐analysis to network meta‐analysis , 2013, Statistics in medicine.

[82]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[83]  Julian Pt Higgins,et al.  Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis , 2013, Clinical trials.

[84]  Douglas G Altman,et al.  Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews , 2009, BMJ : British Medical Journal.

[85]  Jian Qing Shi,et al.  Meta-Analysis of Multi-Arm Trials Using Empirical Logistic Transform , 2008, The open medical informatics journal.

[86]  C. Karema,et al.  A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial , 2011 .

[87]  Nicky J Welton,et al.  Network meta-analysis with competing risk outcomes. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[88]  Alex J. Sutton,et al.  Evidence Synthesis for Decision Making 2 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[89]  Jeroen P Jansen,et al.  Network meta‐analysis of individual and aggregate level data , 2012, Research synthesis methods.

[90]  Neil Hawkins,et al.  How Far Do You Go? Efficient Searching for Indirect Evidence , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[91]  Shannon Cope,et al.  Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes , 2012, BMC Medical Research Methodology.

[92]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.

[93]  T. Lumley Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.

[94]  Catrin Tudur Smith,et al.  Combining individual patient data and aggregate data in mixed treatment comparison meta‐analysis: Individual patient data may be beneficial if only for a subset of trials , 2013, Statistics in medicine.

[95]  D. J. Spiegelhalter,et al.  Identifying outliers in Bayesian hierarchical models: a simulation-based approach , 2007 .

[96]  John P.A. Ioannidis,et al.  Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses , 2009, Canadian Medical Association Journal.

[97]  F. Song,et al.  Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors , 2012, Research synthesis methods.

[98]  Nicky J Welton,et al.  NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2011 .

[99]  Deborah M Caldwell,et al.  Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. , 2010, Journal of clinical epidemiology.

[100]  Alex J. Sutton,et al.  Overall similarity and consistency assessment scores are not sufficiently accurate for predicting discrepancy between direct and indirect comparison estimates , 2013, Journal of clinical epidemiology.

[101]  Z. Philips,et al.  Network meta‐analysis of parametric survival curves , 2010, Research synthesis methods.

[102]  H. Worthington,et al.  Network meta-analysis of randomised controlled trials: direct and indirect treatment comparisons. , 2011, European journal of oral implantology.

[103]  Mei Lu,et al.  Comparative effectiveness research using matching‐adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention‐deficit/hyperactivity disorder and comorbid oppositional defiant disorder , 2012, Pharmacoepidemiology and drug safety.

[104]  D G Altman,et al.  Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. , 2000, Controlled clinical trials.

[105]  Andrea Messori,et al.  Results can be summarised in a simple figure , 2011, BMJ : British Medical Journal.

[106]  Alan Brennan,et al.  Using mixed treatment comparisons and meta‐regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis , 2007, Statistics in Medicine.

[107]  Kristian Thorlund,et al.  How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.

[108]  Deborah M Caldwell,et al.  Validity of indirect comparisons in meta-analysis , 2007, The Lancet.

[109]  Tatyana Shamliyan,et al.  A Bayesian Missing Data Framework for Multiple Continuous Outcome Mixed Treatment Comparisons , 2013 .

[110]  Neil Hawkins,et al.  Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial , 2010, BMC medical research methodology.

[111]  Gordon H Guyatt,et al.  Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison , 2009, Trials.

[112]  A E Ades,et al.  Meta‐analysis of mixed treatment comparisons at multiple follow‐up times , 2007, Statistics in medicine.

[113]  Nicky J Welton,et al.  Study designs to detect sponsorship and other biases in systematic reviews. , 2010, Journal of clinical epidemiology.

[114]  Dimitris Mavridis,et al.  A fully Bayesian application of the Copas selection model for publication bias extended to network meta‐analysis , 2013, Statistics in medicine.

[115]  J. Ioannidis,et al.  Indirect comparisons: the mesh and mess of clinical trials , 2006, The Lancet.